Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael R. Wiley is active.

Publication


Featured researches published by Michael R. Wiley.


The New England Journal of Medicine | 2015

Molecular Evidence of Sexual Transmission of Ebola Virus

Suzanne Mate; Jeffrey R. Kugelman; Tolbert Nyenswah; Jason T. Ladner; Michael R. Wiley; Thierry Cordier-Lassalle; Athalia Christie; Gary P. Schroth; Stephen M. Gross; Gloria J. Davies-Wayne; Shivam A. Shinde; Ratnesh Murugan; Sonpon B. Sieh; Moses Badio; Lawrence S. Fakoli; Fahn Taweh; Emmie de Wit; Vincent J. Munster; James Pettitt; Karla Prieto; Ben W. Humrighouse; Ute Ströher; Joseph W. Diclaro; Lisa E. Hensley; Randal J. Schoepp; David Safronetz; Joseph N. Fair; Jens H. Kuhn; David J. Blackley; A. Scott Laney

A suspected case of sexual transmission from a male survivor of Ebola virus disease (EVD) to his female partner (the patient in this report) occurred in Liberia in March 2015. Ebola virus (EBOV) genomes assembled from blood samples from the patient and a semen sample from the survivor were consistent with direct transmission. The genomes shared three substitutions that were absent from all other Western African EBOV sequences and that were distinct from the last documented transmission chain in Liberia before this case. Combined with epidemiologic data, the genomic analysis provides evidence of sexual transmission of EBOV and evidence of the persistence of infective EBOV in semen for 179 days or more after the onset of EVD. (Funded by the Defense Threat Reduction Agency and others.).


Mbio | 2014

Standards for Sequencing Viral Genomes in the Era of High-Throughput Sequencing

Jason T. Ladner; Brett Beitzel; Patrick Chain; Matthew G. Davenport; Eric Donaldson; Matthew B. Frieman; Jeffrey R. Kugelman; Jens H. Kuhn; Pardis C. Sabeti; David E. Wentworth; Michael R. Wiley; Guo-Yun Yu; Shanmuga Sozhamannan; Christopher Bradburne; Gustavo Palaciosa; Fort Detrick; Fort Belvoir; GoldBelt Raven

ABSTRACT Thanks to high-throughput sequencing technologies, genome sequencing has become a common component in nearly all aspects of viral research; thus, we are experiencing an explosion in both the number of available genome sequences and the number of institutions producing such data. However, there are currently no common standards used to convey the quality, and therefore utility, of these various genome sequences. Here, we propose five “standard” categories that encompass all stages of viral genome finishing, and we define them using simple criteria that are agnostic to the technology used for sequencing. We also provide genome finishing recommendations for various downstream applications, keeping in mind the cost-benefit trade-offs associated with different levels of finishing. Our goal is to define a common vocabulary that will allow comparison of genome quality across different research groups, sequencing platforms, and assembly techniques.


Nature | 2017

Genomic epidemiology reveals multiple introductions of Zika virus into the United States

Nathan D. Grubaugh; Jason T. Ladner; Moritz U. G. Kraemer; Gytis Dudas; Amanda L. Tan; Karthik Gangavarapu; Michael R. Wiley; Stephen White; Julien Thézé; Diogo M. Magnani; Karla Prieto; Daniel Reyes; Andrea M. Bingham; Lauren M. Paul; Refugio Robles-Sikisaka; Glenn Oliveira; Darryl Pronty; Carolyn M. Barcellona; Hayden C. Metsky; Mary Lynn Baniecki; Kayla G. Barnes; Bridget Chak; Catherine A. Freije; Adrianne Gladden-Young; Andreas Gnirke; Cynthia Y. Luo; Bronwyn MacInnis; Christian B. Matranga; Daniel J. Park; James Qu

Zika virus (ZIKV) is causing an unprecedented epidemic linked to severe congenital abnormalities. In July 2016, mosquito-borne ZIKV transmission was reported in the continental United States; since then, hundreds of locally acquired infections have been reported in Florida. To gain insights into the timing, source, and likely route(s) of ZIKV introduction, we tracked the virus from its first detection in Florida by sequencing ZIKV genomes from infected patients and Aedes aegypti mosquitoes. We show that at least 4 introductions, but potentially as many as 40, contributed to the outbreak in Florida and that local transmission is likely to have started in the spring of 2016—several months before its initial detection. By analysing surveillance and genetic data, we show that ZIKV moved among transmission zones in Miami. Our analyses show that most introductions were linked to the Caribbean, a finding corroborated by the high incidence rates and traffic volumes from the region into the Miami area. Our study provides an understanding of how ZIKV initiates transmission in new regions.


Nature | 2017

Virus genomes reveal factors that spread and sustained the Ebola epidemic

Gytis Dudas; Luiz Max Carvalho; Trevor Bedford; Andrew J. Tatem; Guy Baele; Nuno Rodrigues Faria; Daniel J. Park; Jason T. Ladner; Armando Arias; Danny A. Asogun; Filip Bielejec; Sarah Caddy; Matthew Cotten; Jonathan D’ambrozio; Simon Dellicour; Antonino Di Caro; Joseph W. Diclaro; Sophie Duraffour; Michael J. Elmore; Lawrence S. Fakoli; Ousmane Faye; Merle L. Gilbert; Sahr M. Gevao; Stephen K. Gire; Adrianne Gladden-Young; Andreas Gnirke; Augustine Goba; Donald S. Grant; Bart L. Haagmans; Julian A. Hiscox

The 2013–2016 West African epidemic caused by the Ebola virus was of unprecedented magnitude, duration and impact. Here we reconstruct the dispersal, proliferation and decline of Ebola virus throughout the region by analysing 1,610 Ebola virus genomes, which represent over 5% of the known cases. We test the association of geography, climate and demography with viral movement among administrative regions, inferring a classic ‘gravity’ model, with intense dispersal between larger and closer populations. Despite attenuation of international dispersal after border closures, cross-border transmission had already sown the seeds for an international epidemic, rendering these measures ineffective at curbing the epidemic. We address why the epidemic did not spread into neighbouring countries, showing that these countries were susceptible to substantial outbreaks but at lower risk of introductions. Finally, we reveal that this large epidemic was a heterogeneous and spatially dissociated collection of transmission clusters of varying size, duration and connectivity. These insights will help to inform interventions in future epidemics.


Emerging Infectious Diseases | 2015

Monitoring of Ebola virus Makona evolution through establishment of advanced genomic capability in Liberia

Jeffrey R. Kugelman; Michael R. Wiley; Suzanne Mate; Jason T. Ladner; Brett Beitzel; Lawrence S. Fakoli; Fahn Taweh; Karla Prieto; Joseph W. Diclaro; Timothy D. Minogue; Randal J. Schoepp; Kurt E. Schaecher; James Pettitt; Stacey L. Bateman; Joseph N. Fair; Jens H. Kuhn; Lisa E. Hensley; Daniel J. Park; Pardis C. Sabeti; Mariano Sanchez-Lockhart; Fatorma K. Bolay; Gustavo Palacios

The effects of EBOV evolution on diagnostic assays and therapeutic drugs appear to be low.


Cell Host & Microbe | 2015

Evolution and Spread of Ebola Virus in Liberia, 2014–2015

Jason T. Ladner; Michael R. Wiley; Suzanne Mate; Gytis Dudas; Karla Prieto; Sean Lovett; Elyse R. Nagle; Brett Beitzel; Merle L. Gilbert; Lawrence S. Fakoli; Joseph W. Diclaro; Randal J. Schoepp; Joseph N. Fair; Jens H. Kuhn; Lisa E. Hensley; Daniel J. Park; Pardis C. Sabeti; Andrew Rambaut; Mariano Sanchez-Lockhart; Fatorma K. Bolay; Jeffrey R. Kugelman; Gustavo Palacios

The 2013-present Western African Ebola virus disease (EVD) outbreak is the largest ever recorded with >28,000 reported cases. Ebola virus (EBOV) genome sequencing has played an important role throughout this outbreak; however, relatively few sequences have been determined from patients in Liberia, the second worst-affected country. Here, we report 140 EBOV genome sequences from the second wave of the Liberian outbreak and analyze them in combination with 782 previously published sequences from throughout the Western African outbreak. While multiple early introductions of EBOV to Liberia are evident, the majority of Liberian EVD cases are consistent with a single introduction, followed by spread and diversification within the country. Movement of the virus within Liberia was widespread, and reintroductions from Liberia served as an important source for the continuation of the already ongoing EVD outbreak in Guinea. Overall, little evidence was found for incremental adaptation of EBOV to the human host.


Science Advances | 2016

Reduced evolutionary rate in reemerged Ebola virus transmission chains.

David J. Blackley; Michael R. Wiley; Jason T. Ladner; Mosoka Fallah; Terrence Lo; Merle L. Gilbert; Christopher J. Gregory; Jonathan D’ambrozio; Stewart Coulter; Suzanne Mate; Zephaniah Balogun; Jeffrey R. Kugelman; William Nwachukwu; Karla Prieto; Adolphus Yeiah; Fred Amegashie; Brian Kearney; Meagan Wisniewski; John Saindon; Gary P. Schroth; Lawrence S. Fakoli; Joseph W. Diclaro; Jens H. Kuhn; Lisa E. Hensley; Peter B. Jahrling; Ute Ströher; Stuart T. Nichol; Moses Massaquoi; Francis Kateh; Peter Clement

Surveillance of Ebola virus disease flare-ups uncovers a reduced rate of Ebola virus evolution during persistent infections. On 29 June 2015, Liberia’s respite from Ebola virus disease (EVD) was interrupted for the second time by a renewed outbreak (“flare-up”) of seven confirmed cases. We demonstrate that, similar to the March 2015 flare-up associated with sexual transmission, this new flare-up was a reemergence of a Liberian transmission chain originating from a persistently infected source rather than a reintroduction from a reservoir or a neighboring country with active transmission. Although distinct, Ebola virus (EBOV) genomes from both flare-ups exhibit significantly low genetic divergence, indicating a reduced rate of EBOV evolution during persistent infection. Using this rate of change as a signature, we identified two additional EVD clusters that possibly arose from persistently infected sources. These findings highlight the risk of EVD flare-ups even after an outbreak is declared over.


Emerging Infectious Diseases | 2017

High Infection Rates for Adult Macaques after Intravaginal or Intrarectal Inoculation with Zika Virus.

Andrew D. Haddow; Aysegul Nalca; Franco Rossi; Lynn J. Miller; Michael R. Wiley; Unai Pérez-Sautu; Samuel C. Washington; Sarah L. Norris; Suzanne E. Wollen-Roberts; Joshua D. Shamblin; Adrienne E. Kimmel; Holly A. Bloomfield; Stephanie M. Valdez; Thomas R. Sprague; Lucia M. Principe; Stephanie A. Bellanca; Stephanie S. Cinkovich; Luis Lugo-Roman; Lisa H. Cazares; William D. Pratt; Gustavo Palacios; Sina Bavari; M. Louise M. Pitt; Farooq Nasar

Unprotected sexual intercourse between persons residing in or traveling from regions with Zika virus transmission is a risk factor for infection. To model risk for infection after sexual intercourse, we inoculated rhesus and cynomolgus macaques with Zika virus by intravaginal or intrarectal routes. In macaques inoculated intravaginally, we detected viremia and virus RNA in 50% of macaques, followed by seroconversion. In macaques inoculated intrarectally, we detected viremia, virus RNA, or both, in 100% of both species, followed by seroconversion. The magnitude and duration of infectious virus in the blood of macaques suggest humans infected with Zika virus through sexual transmission will likely generate viremias sufficient to infect competent mosquito vectors. Our results indicate that transmission of Zika virus by sexual intercourse might serve as a virus maintenance mechanism in the absence of mosquito-to-human transmission and could increase the probability of establishment and spread of Zika virus in regions where this virus is not present.


Genome Announcements | 2016

Complete Genome Sequences of Five Zika Virus Isolates

Jason T. Ladner; Michael R. Wiley; Karla Prieto; Chadwick Yasuda; Elyse R. Nagle; Matthew R. Kasper; Daniel Reyes; Nikolaos Vasilakis; Vireak Heang; Scott C. Weaver; Andrew D. Haddow; Robert B. Tesh; Ly Sovann; Gustavo Palacios

ABSTRACT Zika virus is an emerging human pathogen of great concern due to putative links to microcephaly and Guillain-Barre syndrome. Here, we report the complete genomes, including the 5′ and 3′ untranslated regions, of five Zika virus isolates, one from the Asian lineage and four from the African lineage.


Journal of General Virology | 2014

Genomic and phylogenetic characterization of viruses included in the Manzanilla and Oropouche species complexes of the genus Orthobunyavirus, family Bunyaviridae

Jason T. Ladner; Nazir Savji; Loreen Lofts; Amelia Travassos da Rosa; Michael R. Wiley; Marie C. Gestole; Gail Emilia Rosen; Hilda Guzman; Pedro Fernando da Costa Vasconcelos; Márcio Roberto Teixeira Nunes; Tadeusz J. Kochel; W. Ian Lipkin; Robert B. Tesh; Gustavo Palacios

A thorough characterization of the genetic diversity of viruses present in vector and vertebrate host populations is essential for the early detection of and response to emerging pathogenic viruses, yet genetic characterization of many important viral groups remains incomplete. The Simbu serogroup of the genus Orthobunyavirus, family Bunyaviridae, is an example. The Simbu serogroup currently consists of a highly diverse group of related arboviruses that infect both humans and economically important livestock species. Here, we report complete genome sequences for 11 viruses within this group, with a focus on the large and poorly characterized Manzanilla and Oropouche species complexes. Phylogenetic and pairwise divergence analyses indicated the presence of high levels of genetic diversity within these two species complexes, on a par with that seen among the five other species complexes in the Simbu serogroup. Based on previously reported divergence thresholds between species, the data suggested that these two complexes should actually be divided into at least five species. Together these five species formed a distinct phylogenetic clade apart from the rest of the Simbu serogroup. Pairwise sequence divergences among viruses of this clade and viruses in other Simbu serogroup species complexes were similar to levels of divergence among the other orthobunyavirus serogroups. The genetic data also suggested relatively high levels of natural reassortment, with three potential reassortment events present, including two well-supported events involving viruses known to infect humans.

Collaboration


Dive into the Michael R. Wiley's collaboration.

Top Co-Authors

Avatar

Gustavo Palacios

United States Army Medical Research Institute of Infectious Diseases

View shared research outputs
Top Co-Authors

Avatar

Jason T. Ladner

United States Army Medical Research Institute of Infectious Diseases

View shared research outputs
Top Co-Authors

Avatar

Karla Prieto

United States Army Medical Research Institute of Infectious Diseases

View shared research outputs
Top Co-Authors

Avatar

Jens H. Kuhn

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Jeffrey R. Kugelman

United States Army Medical Research Institute of Infectious Diseases

View shared research outputs
Top Co-Authors

Avatar

Suzanne Mate

United States Army Medical Research Institute of Infectious Diseases

View shared research outputs
Top Co-Authors

Avatar

Daniel Reyes

United States Army Medical Research Institute of Infectious Diseases

View shared research outputs
Top Co-Authors

Avatar

Andrew D. Haddow

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Brett Beitzel

United States Army Medical Research Institute of Infectious Diseases

View shared research outputs
Top Co-Authors

Avatar

Elyse R. Nagle

United States Army Medical Research Institute of Infectious Diseases

View shared research outputs
Researchain Logo
Decentralizing Knowledge